Price
Financials
Consolidated, Rs crore| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 25.06 | 26.51 | 27.81 | 29.59 | 29.57 | 27.69 | 33.90 | 35.00 | 34.17 | 35.67 | 35.75 | 42.77 |
| Expenses | 24.86 | 26.31 | 26.95 | 27.78 | 27.38 | 26.38 | 30.81 | 31.99 | 31.89 | 31.51 | 30.47 | 35.81 |
| Operating Profit | 0.20 | 0.20 | 0.86 | 1.81 | 2.19 | 1.31 | 3.09 | 3.01 | 2.28 | 4.16 | 5.28 | 6.96 |
| OPM % | 0.80% | 0.75% | 3.09% | 6.12% | 7.41% | 4.73% | 9.12% | 8.60% | 6.67% | 11.66% | 14.77% | 16.27% |
| Other Income | 0.41 | 0.37 | 0.43 | -0.51 | 10.63 | 0.87 | 0.10 | 0.27 | 0.36 | 0.33 | 0.76 | 0.61 |
| Interest | 0.49 | 0.53 | 0.52 | 0.49 | 0.43 | 0.19 | 0.18 | 0.18 | 0.22 | 0.20 | 0.17 | 0.15 |
| Depreciation | 1.13 | 1.16 | 1.15 | 1.28 | 1.29 | 1.31 | 0.90 | 1.12 | 1.13 | 1.14 | 1.13 | 1.13 |
| Profit before tax | -1.01 | -1.12 | -0.38 | -0.47 | 11.10 | 0.68 | 2.11 | 1.98 | 1.29 | 3.15 | 4.74 | 6.29 |
| Tax % | 10.89% | -4.46% | 152.63% | 48.94% | 11.98% | 60.29% | 24.64% | 34.85% | 42.64% | 27.94% | 24.89% | 27.03% |
| Net Profit | -1.13 | -1.06 | -0.97 | -0.70 | 9.76 | 0.27 | 1.58 | 1.29 | 0.74 | 2.27 | 3.56 | 4.59 |
| EPS in Rs | -2.27 | -2.61 | -2.19 | -1.66 | 14.95 | -0.51 | -0.08 | 0.75 | -0.20 | 1.59 | 1.85 | 2.54 |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|
| Sales | 69 | 127 | 101 | 104 | 121 | 141 | 148 |
| Expenses | 60 | 108 | 98 | 103 | 112 | 126 | 130 |
| Operating Profit | 8 | 19 | 3 | 1 | 9 | 15 | 19 |
| OPM % | 12% | 15% | 3.3% | 1.1% | 7% | 11% | 13% |
| Other Income | 1 | 3 | 2 | 2 | 11 | 2 | 2 |
| Interest | 2 | 2 | 2 | 2 | 1 | 1 | 1 |
| Depreciation | 5 | 4 | 4 | 5 | 5 | 5 | 5 |
| Profit before tax | 3 | 16 | -1 | -4 | 13 | 11 | 15 |
| Tax % | 50% | 25% | 161% | 23% | 19% | 30% | |
| Net Profit | 1 | 12 | -2 | -5 | 11 | 8 | 11 |
| EPS in Rs | -0.56 | 8.44 | -8.05 | -10.61 | 12.69 | 3.98 | 5.78 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | % | 15% | 12% | 18% | ||
| Compounded Profit Growth | % | 49% | 35% | -61% | ||
| Stock Price CAGR | 10% | -3% | 19% | 30% | ||
| Return on Equity | % | -1% | -2% | 3% |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Equity Capital | 5 | 5 | 6 | 6 | 6 | 6 |
| Reserves | 49 | 55 | 63 | 57 | 65 | 67 |
| Borrowings | 21 | 23 | 17 | 22 | 8 | 9 |
| Other Liabilities | 62 | 62 | 66 | 76 | 70 | 85 |
| Total Liabilities | 136 | 144 | 152 | 161 | 148 | 167 |
| Fixed Assets | 71 | 68 | 85 | 87 | 74 | 71 |
| CWIP | 0 | 9 | 0 | 0 | 1 | 4 |
| Investments | 2 | 0 | 0 | 3 | 0 | 12 |
| Other Assets | 63 | 66 | 67 | 71 | 73 | 81 |
| Total Assets | 136 | 144 | 152 | 161 | 148 | 167 |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Cash from Operating Activity | 0 | 18 | -9 | 1 | -4 | 14 |
| Cash from Investing Activity | 0 | -22 | 1 | -7 | 20 | -15 |
| Cash from Financing Activity | 0 | 0 | 6 | 6 | -16 | 0 |
| Net Cash Flow | 0 | -3 | -2 | -0 | -0 | -0 |
| Free Cash Flow | 0 | 9 | -21 | -6 | 11 | 11 |
| CFO/OP | 0% | 128% | -185% | 232% | -20% | 118% |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Debtor Days | 88 | 39 | 72 | 70 | 85 | 52 |
| Inventory Days | 344 | 166 | 281 | 227 | 230 | 250 |
| Days Payable | 182 | 38 | 91 | 112 | 79 | 110 |
| Cash Conversion Cycle | 250 | 167 | 262 | 185 | 236 | 192 |
| Working Capital Days | 112 | 61 | 113 | 97 | 140 | 106 |
| ROCE % | 15% | 1% | -2% | 4% | 9% |
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 61.28% | 61.28% | 61.28% | 61.28% | 61.28% | 61.28% | 61.28% | 61.28% | 61.28% | 61.28% | 61.28% | 61.28% |
| DIIs | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.39% | 0.39% | 0.39% | 0.39% | 0.39% | 0.39% | 0.39% |
| Public | 38.73% | 38.74% | 38.73% | 38.74% | 38.73% | 38.33% | 38.34% | 38.35% | 38.35% | 38.35% | 38.34% | 38.34% |
| No. of Shareholders | 4,283 | 4,179 | 4,176 | 4,090 | 4,008 | 4,031 | 4,135 | 4,073 | 4,026 | 3,926 | 3,801 | 3,745 |
Fundamentals
Market Cap₹ 107 Cr.
Current Price₹ 188
Stock P/E31.3
Book Value₹ 124
ROCE9.28 %
ROE3.17 %
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)18%
Compounded Profit Growth (TTM)-61%
Consolidated figures.
Valuation
Market capRs 90 Cr
Enterprise valueRs 105 Cr
P/E (TTM)26.46x
Price to book1.51x
Price to sales0.61x
EV / EBITDA5.04x
EV / EBIT6.45x
EV / sales0.70x
Price to cash flow4.88x
Earnings yield3.78%
Profitability
Operating margin (excl. other income)14.90%
Operating margin (incl. other income)16.91%
EBITDA margin13.98%
Pre-tax margin10.43%
Net profit margin2.30%
Net margin, latest quarter3.51%
ROE8.76%
ROCE22.17%
ROA3.55%
ROIC (approx.)16.38%
Tax rate25.30%
Other income / net worth4.28%
Growth
Sales growth (latest year)85.02%
Sales growth QoQ19.64%
Profit growth QoQ37.61%
Sales growth YoY (latest quarter)22.20%
Profit growth YoY (latest quarter)240.91%
Per share
EPS (TTM)Rs 6.94
EPS (latest year)Rs 10.13
EPS (latest quarter)Rs 3.05
Book value per shareRs 121.17
Sales per shareRs 301.73
Cash flow per shareRs 37.62
Free cash flow per shareRs 22.37
Efficiency
Asset turnover0.88x
Fixed asset turnover1.86x
Inventory turnover3.53x
Inventory days103 days
Debtor days39 days
Debtors turnover9.36x
Creditor days110 days
Cash conversion cycle192 days
Working capital days106 days
Leverage
Total debtRs 23 Cr
Cash and bankRs 9 Cr
Net debtRs 14 Cr
Debt to equity0.39x
Net debt / EBITDA0.69x
Interest coverage21.91x
Owners' fund to total sources41.28%
Debt to assets15.94%
Cash flow
Cash from Operating Activity (latest year)Rs 18 Cr
Cash from Investing Activity (latest year)Rs -22 Cr
Cash from Financing Activity (latest year)Rs 0 Cr
Net Cash Flow (latest year)Rs -3 Cr
Free cash flow (latest year)Rs 11 Cr
FCFE (approx.: FCF + change in debt)Rs 13 Cr
Cash from ops / profit, 5 years0.83x
Sales to cash flow6.86x
Statement figures
Net sales (TTM)Rs 148 Cr
Net sales (latest year)Rs 127 Cr
Sales (latest quarter)Rs 43 Cr
Operating profit excl. other income (latest year)Rs 19 Cr
Operating profit (latest quarter)Rs 7 Cr
Other income (TTM)Rs 2 Cr
EBITDA (TTM)Rs 21 Cr
PBDT (TTM)Rs 20 Cr
Profit before tax (TTM)Rs 15 Cr
Tax (latest year)Rs 4 Cr
Net profit (TTM)Rs 3 Cr
Net profit (latest year)Rs 5 Cr
Net profit (latest quarter)Rs 2 Cr
Depreciation (TTM)Rs 5 Cr
Depreciation (latest quarter)Rs 1 Cr
Interest (TTM)Rs 1 Cr
Cost of goods sold (latest year)Rs 84 Cr
Total expenditure (latest year)Rs 108 Cr
Total income (latest year)Rs 129 Cr
Share capitalRs 5 Cr
ReservesRs 55 Cr
Shareholders' fundsRs 60 Cr
Total assetsRs 144 Cr
Net blockRs 68 Cr
Capital work in progressRs 9 Cr
InvestmentsRs 0 Cr
ReceivablesRs 14 Cr
InventoryRs 24 Cr
Other liabilitiesRs 62 Cr
Shares outstanding (crore)0.49
Ownership
Promoter holding61.28% (+0.00 in a year)
Computed by MarketFriction from the consolidated statements. Returns use average balances.
Not enough history to build valuation bands (needs two years of profits and prices).
| Period | MAKERSL | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | -3.1% | -2.8% | -0.3 pts |
| 1 month | -2.2% | -6.8% | +4.6 pts |
| 3 years | +70.1% | +14.2% | +55.9 pts |
| 5 years | -13.5% | +27.9% | -41.4 pts |
Red flags
F-score 7 of 8No red flags in the latest statements and filings.
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Jun 2026Sales ₹43 Cr +22.2% vs Jun 2025.
Net profit ₹5 Cr +255.8%.
Against our estimate for Jun 2026: sales +4.3%, profit +122.8% beat. Our estimate for Sep 2026: sales Rs 39 Cr, profit Rs 3 Cr (how).
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | 447,476 | 35.4 | 20.5 % |
| Divis Laboratories Ltd | 250,363 | 84.0 | 22.0 % |
| Torrent Pharmaceuticals Ltd | 186,152 | 83.4 | 15.2 % |
| Zydus Lifesciences Ltd | 119,750 | 24.6 | 21.1 % |
| Cipla Ltd | 111,430 | 31.1 | 15.5 % |
| Laurus Labs Ltd | 106,928 | 97.8 | 17.8 % |
| Mankind Pharma Ltd | 105,120 | 49.3 | 13.5 % |
| Dr Reddys Laboratories Ltd | 104,494 | 32.4 | 13.0 % |
| Aurobindo Pharma Ltd | 97,682 | 25.8 | 12.9 % |
| Lupin Ltd | 93,840 | 15.8 | 29.9 % |
| Glenmark Pharmaceuticals Ltd | 68,905 | 22.1 | 39.8 % |
| Alkem Laboratories Ltd | 62,772 | 27.6 | 21.2 % |
| Biocon Ltd | 61,439 | 84.5 | 3.61 % |
| Abbott India Ltd | 57,949 | 35.9 | 44.8 % |
| Gland Pharma Ltd | 49,333 | 43.1 | 15.1 % |
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Less than 100 unique PAN traded in previous 30 days
Quick answers
What is the market cap of Makers Laboratories Ltd?
Makers Laboratories Ltd (MAKERSL) has a market capitalisation of Rs 107 Cr. at the 2026-10-01 close.
What is the P/E ratio of Makers Laboratories Ltd?
Makers Laboratories Ltd trades at a P/E of 31.3 on trailing twelve-month profit, at the 2026-10-01 close.
What were Makers Laboratories Ltd's latest quarterly results?
In the Jun 2026 quarter, Makers Laboratories Ltd sales was Rs 43 Cr (+22.2% vs Jun 2025) and net profit was Rs 5 Cr.
What is the 52-week high and low of Makers Laboratories Ltd?
The 52-week high is Rs 236.00 and the 52-week low is Rs 150.00.